Substitution on the A-Ring Confers to Bryopyran Analogues the Unique Biological Activity Characteristic of Bryostatins and Distinct From That of the Phorbol Esters
摘要:
A close structural analogue of bryostatin 1, which differs from bryostatin 1 only by the absence of the C-30 carbomethoxy group (on the C-13 enoate of the B-ring), has been prepared by total synthesis. Biological assays reveal a crucial role for substitution in the bryostatin 1 A-ring in conferring those responses which are characteristic of bryostatin 1 and distinct from those observed with PMA.
BRYOSTATIN ANALOGS AND USE THEREOF AS ANTIVIRAL AGENTS
申请人:UNIVERSITY OF UTAH RESEARCH FOUNDATION
公开号:US20170239212A1
公开(公告)日:2017-08-24
Described herein are tricyclic macrolactones. The macrolactones have a high binding affinity for PKC. The compounds described herein can be used in a number of therapeutic applications including the treatment or prevention of viral infection. Also described herein are methods for producing macrolactones. The methods permit the high-yield synthesis of macrolactones in a low number of steps and with a high degree of substitution and specificity.